This topic contains a solution. Click here to go to the answer

Author Question: A patient who has received heparin after previous surgeries will be given enoxaparin sodium ... (Read 49 times)

acc299

  • Hero Member
  • *****
  • Posts: 569
A patient who has received heparin after previous surgeries will be given enoxaparin sodium (Lovenox) after knee-replacement surgery. The patient asks how this drug is different from heparin. The nurse will explain that enoxaparin
 
  a. decreases the need for laboratory tests.
  b. has a shorter half-life than heparin.
  c. increases the risk of hemorrhage.
  d. may be taken orally instead of subcutaneously.

Question 2

The nurse is caring for a patient who is receiving warfarin (Coumadin) and notes bruising and petechiae on the patient's extremities. The nurse will request an order for which laboratory test?
 
  a. International normalized ratio (INR)
  b. Platelet level
  c. Partial thromboplastin time (PTT) and activated partial thromboplastin time (aPTT)
  d. Vitamin K level



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Laurenleakan

  • Sr. Member
  • ****
  • Posts: 309
Answer to Question 1

ANS: A
Enoxaparin is a lowmolecular-weight heparin, which produces more stable responses at lower doses, thus reducing the need for frequent lab monitoring. It has a longer half-life than heparin. It decreases the risk of hemorrhage because it is more stable at lower doses. It is given subcutaneously.

Answer to Question 2

ANS: A
The INR is the test used most frequently to report prothrombin time results in patients taking warfarin. Warfarin is not an antiplatelet drug, so platelet levels are not indicated. PTT and aPTT are used to monitor heparin therapy. Vitamin K is an antidote for warfarin; levels are not routinely checked.




acc299

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
Gracias!


jackie

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Excellent

 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

For a complete list of videos, visit our video library